QUANTUMAI

Serial Number 99125636
680

Registration Progress

Application Filed
Apr 8, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Examiner's Amendment Completed
Due: Aug 08, 2025 9 days

Trademark Image

QUANTUMAI

Basic Information

Serial Number
99125636
Filing Date
April 8, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
680
Status Date
Jul 24, 2025
Application
Pending
Classes
042 044

Rights Holder

Caris MPI, Inc.

03
Address
750 West John Carpenter Freeway Ste. 800
Irving, TX 75039

Ownership History

Caris MPI, Inc.

Original Applicant
03
Irving, TX

Legal Representation

Attorney
Anne Fleeson

USPTO Deadlines

Next Deadline
9 days remaining
Examiner's Amendment Completed
Due Date
August 08, 2025

Application History

9 events
Date Code Type Description Documents
Jul 24, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 24, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 24, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 24, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 24, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 17, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 11, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 8, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 8, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization of cancer, genomic and transcriptomic characteristics, tumor microenvironment, and determination of biosignatures using bioinformatics and artificial intelligence; providing medical research information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)
Class 044
Providing medical information to patients and medical professionals in the form of reports in the field of molecular profiling for the diagnosis, treatment and monitoring of cancer; providing medical information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)

Classification

International Classes
042 044